Novel oral anticoagulants and HIV: dabigatran use with antiretrovirals
- PMID: 26590187
- PMCID: PMC4680264
- DOI: 10.1136/bcr-2015-211651
Novel oral anticoagulants and HIV: dabigatran use with antiretrovirals
Abstract
Compatibility of novel oral anticoagulants in patients with HIV taking combined antiretroviral therapy has not been established, with no published reports of successful concurrent use. We present a case where chronic anticoagulation was indicated in a patient with treated HIV and non-valvular atrial fibrillation who refused warfarin therapy. The patient tolerated the combination, with dabigatran blood levels within the expected range at a standard dosing regimen, without evidence of bleeding or other adverse outcomes. While further research is needed to establish the role of novel oral anticoagulants in patients taking antiretrovirals, this case suggests that dabigatran may be a viable option for selected patients.
2015 BMJ Publishing Group Ltd.
References
-
- Camm AJ, Kirchhof P, Lip GY et al. , European Heart Rhythm Association. European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369–429. 10.1093/eurheartj/ehq278 - DOI - PubMed
-
- Wong CX, Brooks AG, Leong DP et al. . The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: a 15 year study of all hospitalizations in Australia. Arch Intern Med 2010;172:739–41. - PubMed
-
- January CT, Wann S, Alpert JS et al. . 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014;64:e1–76. 10.1016/j.jacc.2014.03.022 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical